| A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease MA Pfeffer, EA Burdmann, CY Chen, ME Cooper, D De Zeeuw, ... New England Journal of Medicine 361 (21), 2019-2032, 2009 | 2443 | 2009 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2241 | 2006 |
| Cardiorenal end points in a trial of aliskiren for type 2 diabetes HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ... New England Journal of Medicine 367 (23), 2204-2213, 2012 | 1636 | 2012 |
| Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial GL Bakris, V Fonseca, RE Katholi, JB McGill, FH Messerli, RA Phillips, ... Jama 292 (18), 2227-2236, 2004 | 1206 | 2004 |
| Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm … AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ... Endocrine Practice 23 (2), 207-238, 2017 | 1148 | 2017 |
| Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial RW Beck, T Riddlesworth, K Ruedy, A Ahmann, R Bergenstal, S Haller, ... Jama 317 (4), 371-378, 2017 | 1142 | 2017 |
| AACE comprehensive diabetes management algorithm 2013 AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ... Endocrine practice: official journal of the American College of …, 2013 | 1140* | 2013 |
| Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study PA Hollander, SC Elbein, IB Hirsch, D Kelley, J McGill, T Taylor, SR Weiss, ... Diabetes care 21 (8), 1288-1294, 1998 | 967 | 1998 |
| The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study WF Keane, BM Brenner, D De Zeeuw, JP Grunfeld, J McGill, WE Mitch, ... Kidney international 63 (4), 1499-1507, 2003 | 754 | 2003 |
| Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm … AJ Garber, Y Handelsman, G Grunberger, D Einhorn, MJ Abrahamson, ... Endocrine Practice 26 (1), 107-139, 2020 | 640 | 2020 |
| Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial PJ Lustman, LS Griffith, RE Clouse, KE Freedland, SA Eisen, EH Rubin, ... Psychosomatic medicine 59 (3), 241-250, 1997 | 631 | 1997 |
| Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm … AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ... Endocrine Practice 22 (1), 84-113, 2016 | 626 | 2016 |
| Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants KM Miller, RW Beck, RM Bergenstal, RS Goland, MJ Haller, JB McGill, ... Diabetes care 36 (7), 2009-2014, 2013 | 587 | 2013 |
| American Association of Clinical Endocrinologists and American College of Endocrinology–clinical practice guidelines for developing a diabetes mellitus comprehensive care plan … Y Handelsman, ZT Bloomgarden, G Grunberger, G Umpierrez, ... Endocrine Practice 21 (4), 413-437, 2015 | 585 | 2015 |
| Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial RW Beck, TD Riddlesworth, K Ruedy, A Ahmann, S Haller, D Kruger, ... Annals of internal medicine 167 (6), 365-374, 2017 | 528 | 2017 |
| Anxiety and poor glycemic control: a meta-analytic review of the literature RJ Anderson, AB Grigsby, KE Freedland, M De Groot, JB McGill, ... The International Journal of Psychiatry in Medicine 32 (3), 235-247, 2002 | 466 | 2002 |
| Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients JB McGill, DJ Schneider, CL Arfken, CL Lucore, BE Sobel Diabetes 43 (1), 104-109, 1994 | 418 | 1994 |
| The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American … LM Laffel, JB McGill, DJ Gans The American journal of medicine 99 (5), 497-504, 1995 | 391 | 1995 |
| The effect of ruboxistaurin on nephropathy in type 2 diabetes KR Tuttle, GL Bakris, RD Toto, JB McGill, K Hu, PW Anderson Diabetes care 28 (11), 2686-2690, 2005 | 367 | 2005 |
| Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study P Raskin, BW Bode, JB Marks, IB Hirsch, RL Weinstein, JB McGill, ... Diabetes care 26 (9), 2598-2603, 2003 | 359 | 2003 |
